INSYS THERAPEUTICS INC NEW's ticker is and the CUSIP is 45824V909. A total of 3 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $0 | -100.0% | 5 | -90.0% | 0.00% | – |
| Q1 2019 | $23,000 | +109.1% | 50 | +51.5% | 0.00% | – |
| Q4 2018 | $11,000 | -86.6% | 33 | -59.8% | 0.00% | – |
| Q3 2018 | $82,000 | -37.4% | 82 | -54.9% | 0.00% | -100.0% |
| Q2 2018 | $131,000 | +991.7% | 182 | +70.1% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | -70.7% | 107 | -15.7% | 0.00% | -50.0% |
| Q4 2017 | $41,000 | +1950.0% | 127 | +119.0% | 0.00% | – |
| Q3 2017 | $2,000 | -96.2% | 58 | -78.4% | 0.00% | -100.0% |
| Q2 2017 | $52,000 | +4.0% | 269 | -38.3% | 0.00% | 0.0% |
| Q1 2017 | $50,000 | +614.3% | 436 | -3.1% | 0.00% | – |
| Q4 2016 | $7,000 | 0.0% | 450 | +20.0% | 0.00% | – |
| Q3 2016 | $7,000 | – | 375 | +4066.7% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 9 | -97.5% | 0.00% | -100.0% |
| Q1 2016 | $30,000 | -65.9% | 358 | +108.1% | 0.00% | -71.4% |
| Q4 2015 | $88,000 | +1157.1% | 172 | +681.8% | 0.01% | +600.0% |
| Q3 2015 | $7,000 | -92.6% | 22 | -75.6% | 0.00% | -87.5% |
| Q2 2015 | $95,000 | +21.8% | 90 | +55.2% | 0.01% | -11.1% |
| Q1 2015 | $78,000 | +95.0% | 58 | -13.4% | 0.01% | +80.0% |
| Q4 2014 | $40,000 | – | 67 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 151,700 | $5,449,000 | 0.08% |
| SIMPLEX TRADING, LLC | 90 | $95,000 | 0.01% |
| Citadel Advisors | 46,200 | $1,660,000 | 0.00% |